Hideyuki Takizawa | Internal Medicine | Best Researcher Award

Posted on by Innovator Awards

Dr. Hideyuki Takizawa | Internal Medicine | Best Researcher Award

The University of Tokyo | Japan

Dr. Hideyuki Takizawa is Chief Medical Officer and Chief Research Officer at Cliffhanger Inc., where he also leads the Division of Clinical Operations and Clinical Research Development (CROs and pharmaceutical companies) in Tokyo. He earned his MD and MSc from the Graduate School of Medicine at The University of Tokyo, followed by a PhD in Internal Medicine, awarded with honours for scientific research excellence and a translational medicine award. His doctoral work spanned clinical laboratory medicine and internal medicine, and focused on the biochemical and clinical mechanisms that link lipid metabolism to metabolic and cardiovascular disease, especially diabetes mellitus. Dr. Takizawa’s research has centred on serum sphingolipids and glycerophospholipids—specifically lipid subclasses such as phosphatidylinositol/lysophosphatidylinositol, phosphatidylglycerol/lysophosphatidylglycerol, and ceramides—and their associations with diabetes and its vascular and metabolic complications. He has applied omics-based lipid profiling to integrate molecular, cellular and clinical observations, thereby advancing translational medicine and precision treatment strategies for metabolic disorders.

Profile: Orcid 

Featured Publications 

Takizawa, H., Uranbileg, B., Yutaka, Y., & Kurano, M. (2025). Serum sphingolipid and glycerophospholipid synthesis, especially phosphatidylinositol/lysophosphatidylinositol, phosphatidylglycerol/lysophosphatidylglycerol, and ceramides, are significantly influenced by diabetes mellitus and associated with its complications. Diabetology, 6(10), Article 112.

Neriman Yükseltürk Şimşek | Breast Cancer | Best Researcher Award

Posted on by Innovator Awards

Assist. Prof. Dr. Neriman Yükseltürk Şimşek | Breast Cancer | Best Researcher Award

Ankara University | Turkey

Dr. Neriman Yükseltürk Şimşek is an Assistant Professor in the Department of Nursing at Ankara University, Turkey. With over two decades of clinical experience in intensive and emergency care nursing, she transitioned to academia after completing her master's and doctoral degrees. Her research primarily focuses on enhancing the quality of life for cancer patients through innovative, evidence-based nursing interventions. Dr. Şimşek has conducted significant studies on the effects of complementary therapies—such as reflexology, cold application, and exercise—on chemotherapy-induced side effects like peripheral neuropathy, nausea, vomiting, and anxiety PubMed+1. She has also contributed to the Turkish validation of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool PubMed. Her scholarly work has been published in reputable journals, including the Asia-Pacific Journal of Oncology Nursing and Complementary Medicine Research. Dr. Şimşek's research has been cited over 50 times, reflecting her impact in the field. Her commitment to patient-centered care and quality of life continues to drive her academic and clinical endeavors.

Profile: Orcid 

Featured Publications 

Kurt, G., Tarus, H. A., & Yükseltürk Şimşek, N. (2025). Assessment of Survivor Concerns Scale for gynecological cancer: Turkish validity and reliability study. Seminars in Oncology Nursing.

 Yükseltürk Şimşek, N., & Demir, A. (2024). Determining the impact of the COVID-19 pandemic on depression, anxiety and stress levels in cancer patients. Kafkas Journal of Medical Sciences.

Yükseltürk Şimşek, N. (2022). Determining the effect of reflexology on nausea, vomiting and anxiety in patients with breast cancer receiving chemotherapy: A randomized controlled study.

 Yükseltürk Şimşek, N. (n.d.). Cold application and exercise on development of peripheral neuropathy during taxane chemotherapy in breast cancer patients: A randomized controlled trial.

 Yükseltürk Şimşek, N. (n.d.). Determination of early side effects after COVID-19 vaccinations.

Mr. Rahul Pal – Pharmaceutics – Outstanding Scientist Award

Posted on by Innovator Awards

Mr. Rahul Pal - Pharmaceutics - Outstanding Scientist Award

Jagannath University, Chaksu, Jaipur, Rajasthan, India  - India 

Author Profile 

GOOGLE SCHOLAR 

🎓 Early academic pursuits

Rahul Pal began his academic journey with outstanding results during his formative years. he completed his high school and intermediate education from c. lal v. pal svm i.c., pilibhit, uttar pradesh, securing impressive marks of 83.83% and 86% respectively under the up board. his passion for pharmaceutical sciences became evident as he progressed to earn a bachelor of pharmacy (b. pharm) from invertis university, bareilly, u.p., with a cgpa of 8.27. furthering his education, he pursued a master of pharmacy (m. pharm) in pharmaceutics at nims university rajasthan, where he achieved a cgpa of 7.78. currently, rahul is enrolled in a ph.d. program in pharmaceutical sciences at chitkara university, punjab, beginning from december 2024 onwards.

💼 Professional endeavors

Rahul pal has demonstrated commendable commitment in academia. he started his teaching career as an assistant professor in the department of pharmaceutics at desh bhagat university (dbu), mandi gobindgarh, punjab. shortly after, he transitioned to the prestigious isf college of pharmacy, moga, serving as an assistant professor from august 2024 to april 2025. his dynamic involvement in academic institutions has been key to enriching the field of pharmaceutical sciences.

🔬 Contributions and research focus

rahul’s primary research interest lies in nanotechnology-driven drug delivery systems and their application in improving clinical outcomes. his work explores innovative pharmaceutical techniques, including power electronics-integrated drug formulation technologies, to optimize patient care. he has contributed to major scientific events such as national symposia and Pharmaceutics faculty development programmes, where he has delivered technical talks on ip rights, reputed journal identification, and advanced pharmaceutical systems. his invited lectures consistently emphasize the role of power electronics in automation and controlled drug delivery mechanisms.

🌍 Impact and influence

Rahul pal's influence in the field is evident through his invited speaker roles at multiple reputed national and international conferences. notably, he was invited to present at the world aquaculture, fisheries and seafood international conference (wac2025) in rome, italy, where he discussed the application of nanotechnology in fisheries and aquaculture, showcasing Pharmaceutics cross-disciplinary expertise. in addition, his presence in oral/poster judging panels reflects his recognition as an emerging authority in pharmaceutical academia.

🏆 Accolades and academic cites

Rahul received the prestigious young scientist award 2025 from the scientific laurels international committee, recognizing his promising contributions to the scientific community. his Pharmaceutics academic outputs and engagements have garnered attention on professional platforms like linkedin, and his expertise is increasingly cited in conferences and scholarly sessions across india and abroad. he has also been cited in symposiums that emphasize the integration of power electronics in biomedical innovation.

🔍 Legacy and future contributions

with a determined focus on bridging academia with industry and patient care, rahul pal is poised to shape the next era of pharmaceutical innovation. he aims to integrate power electronics, artificial intelligence, and nanoscience into advanced therapeutic solutions. through collaborative projects and cross-border conferences, he envisions establishing a globally recognized footprint in pharmaceutical nanotechnology. rahul’s long-term vision includes mentoring emerging researchers, contributing to policy framing, and pioneering patent-worthy innovations that transform healthcare systems globally.

Notable Publications 

  • Title: The Future Perspectives and Novel Approach on Gastro Retentive Drug Delivery System (GRDDS) with Current State
    Author(s): R. Pal, P. Pandey, L. Nogai, A. Anand, P. Suthar, M. SahdevKeskar, V. Kumar
    Journal: Journal of Population Therapeutics and Clinical Pharmacology

  • Title: The Advanced Approach in the Development of Targeted Drug Delivery (TDD) with Their Bio-Medical Applications: A Descriptive Review
    Author(s): R. Pal, P. Pandey, L. Nogai
    Journal: International Neurourology Journal

  • Title: The Pharmaceutical Polymer’s; A Current Status in Drug Delivery: A Comprehensive Review
    Author(s): R. Pal, P. Pandey, A. Anand, A. Saxena, S.K. Thakur, R.K. Malakar, V. Kumar
    Journal: Journal of Survey in Fisheries Sciences

  • Title: The Utilization of Response Surface Methodology (RSM) in the Optimization of Diclofenac Sodium (DS) Liposomes Formulate through the Thin Film Hydration (TFH) Technique
    Author(s): R. Pal, P. Pandey, M. Rizwan, M. Koli, S.K. Thakur, R.K. Malakar, H. Gupta, ...
    Journal: Journal of Advances in Medicine and Medical Research

  • Title: Design of Experiments (DoE) Manipulation in the Formulation and Optimization of a Traditional Ayurvedic Medicine Derived from Dried Extract of Senegalia catechu
    Author(s): P. Pandey, R. Pal, K.S. Bharath, A. Akilandeshwari, M. Koli, M. Rizwan, ...
    Journal: Journal of Pharmacognosy and Phytochemistry

Assist. Prof. Dr. Natalia Bilousova – Pharmaceutical care  –  Best Researcher Award 

Posted on by Innovator Awards

Assist. Prof. Dr. Natalia Bilousova - Pharmaceutical care  -  Best Researcher Award 

Shupyk National Healthcare University of Ukraine -  Ukraine 

Author Profile 

GOOGLE SCHOLAR 

🎓 Early academic pursuits

Natalia Bilousova embarked on her academic journey with a profound interest in clinical pharmacology. she earned her mph and subsequently a phd, laying a strong foundation in pharmaceutical sciences. her commitment to academic excellence led her to pursue a post-doctoral role at the cardiology department of the shupyk national healthcare university of ukraine in kyiv. early on, she demonstrated a deep inclination toward merging clinical practice with evidence-based research, which later shaped her career trajectory.

💼 Professional endeavors

With over 25 years of professional experience, natalia has worn many hats, including clinical pharmacist, academician, and researcher. she currently serves as an associate professor at the shupyk national healthcare university of ukraine. amidst wartime disruptions, she took part in an academic mobility program in 2022 at masaryk university, czech republic, showing her resilience and dedication to global health education. her participation in consultancy projects with pharmacy chains like “bazhaemo zdorovia” and “apteka nyzkykh tsin” showcases her practical engagement with the healthcare sector. her work in the domain of power electronics provides a novel lens for integrating digital systems in pharmaceutical education.

🔬 Contributions and research focus

Natalia’s research interests span across pharmacology, healthcare policy, pharmaceutical care in cardiovascular diseases, and mental health. her notable contributions include three clinical pharmacology guidelines for managing chronic coronary syndrome, elevated blood pressure, and ischemic heart disease in multidisciplinary teams. she’s also deeply involved in developing Pharmaceutical care continuing professional development (cpd) courses and pharmaceutical training modules. her innovative outlook ties in health technology assessment with real-time patient care — offering new dimensions of analysis, akin to the precision and integration found in power electronics applications.

🌍 Impact and influence

As a national and international speaker, natalia frequently addresses audiences via webcardio.org and scientific forums. her influence spans academia, industry, and public health Pharmaceutical care organizations. she plays an active role in shaping public policies through her board membership in public health and educational groups. her collaborations with pharmaceutical giants like teva, ratiopharm, arterium, and wörwag pharma reflect her trusted expertise in market research and medical promotion. her scholarly presence extends to the conceptual design of pharmaceutical care systems — a model as efficient and structured as a power electronics control scheme in high-demand environments.

📊 Academic cites

Natalia Bilousova’s academic contributions have garnered a citation index of 7 on google scholar and 1 on scopus. while modest, these numbers reflect her growing impact in niche research Pharmaceutical care areas such as health technology assessment and mental health-focused pharmaceutical care. her scholarly output includes six isbn-registered publications, some of which are monographs and methodological guides, including her 2024 work on pharmaceutical care for mental health patients.

📚 Legacy and future contributions

Natalia’s legacy is rooted in her dedication to refining pharmaceutical education and care practices. her recent books delve into topics like professional digital competence and medical technology assessment, emphasizing the evolving role of pharmacists in an increasingly tech-driven world. she is poised to continue her efforts in education transformation, particularly Pharmaceutical care through digitalization and interprofessional healthcare collaboration. future contributions are expected to address mental health services and integrative care models that could revolutionize pharmacy training — much like how power electronics has revolutionized modern energy systems.

Notable Publications 

  • Title: Conceptual model of pharmaceutical care for patients with coronary heart disease and comorbid conditions in Ukraine
    Author: N. Bilousova
    Journal: Journal of Pharmaceutical Policy and Practice

  • Title: Research of affordability to essential medicines for coronary heart disease in Ukraine
    Authors: N. Bilousova, N. Tkachenko, N. Kozhuharyova, M. Dolzhenko
    Journal: Journal of Pharmaceutical Policy and Practice

  • Title : Adherence to treatment of patients with coronary heart disease and comorbid conditions: influence of socio-economic factors during martial law in Ukraine (first report)
    Authors: N.A. Bilousova, V.I. Nesukai, T.V. Simahina, M.M. Dolzhenko, O.P. Shmatenko, et al.
    Journal: Ukrainian Journal of Military Medicine

  • Title: An analysis of prescriptions for coronary heart disease with comorbid conditions in health care institutions of Ukraine
    Authors: N.A. Bilousova, M.M. Dolzhenko
    Journal: Current Issues in Pharmacy and Medicine: Science and Practice

  • Title: Preferences in the choice of original and generic drugs: pharmaceutical care for patients with coronary heart disease and comorbid conditions
    Authors: M.M. Dolzhenko, N.A. Bilousova, V.A. Nesukai, T.V. Simahina, et al.
    Journal: Modern Medical Technologies (Сучасні медичні технології)

Prof. Jerzy trojan – Immuno – gene therapy – Excellence in Innovation

Posted on by Innovator Awards

Prof. Jerzy trojan - Immuno - gene therapy - Excellence in Innovation

CEDEA/ICGT and INSERM/Univ. Paris-Saclay - France

Author Profile

ORCID

Early academic pursuits 🎓

Jerzy trojan completed his doctorate d’état ès sciences (hdr) at the prestigious sorbonne - p&m curie. during this formative period, he laid the groundwork for his future contributions to biomedical science, specifically in the field of cancerology. his early research endeavors, characterized by a rigorous scientific approach, focused on critical aspects of oncology and laid the foundation for his later groundbreaking work.

Professional endeavors 🏥

Jerzy has held various esteemed positions throughout his career, reflecting his commitment to advancing cancer research. he is currently a visiting professor at the insitm, cancer center, and paris-saclay university in villejuif, france, where he has been since 2019. before this, he served as president and research director at the international cancer gene therapy and oncology diagnostics center (ceadea) in bogota, colombia, and has also held prominent roles in institutions across the usa and europe, including case western reserve university and the sidney kimmel cancer center. these diverse experiences have equipped him with a comprehensive understanding of both the scientific and clinical aspects of cancer treatment.

Contributions and research focus 🔬

Dr. trojan is best known for establishing cancer gene therapy, particularly immuno-gene therapy, as a pivotal domain within oncology. his pioneering research, highlighted in publications from 1993, led to significant advancements in the treatment of glioblastoma, showcasing the therapeutic potential of gene therapy. Immuno - gene therapy additionally, he explored the intersection between neuro-ontogenesis and neuro-oncogenesis, identifying afp and igf-i as novel biomarkers, which have implications for understanding central nervous system differentiation and cancer progression.

Accolades and recognition 🏆

In recognition of his substantial contributions to biomedical science, jerzy was elected as a member of the prestigious french academy of medicine (anm) in paris in 2017. his extensive body of work includes nearly 370 publications, encompassing 140 articles, 102 book chapters, and four books, which have garnered over 3,500 Immuno - gene therapy citations. this impressive scholarly output underscores his impact and influence in the field of cancer research.

Impact and influence 🌍

Dr. trojan's research has significantly shaped the landscape of cancer therapy, particularly in immunotherapy. his establishment of immuno-gene therapy has opened new avenues for treating aggressive cancers, thus influencing both academic research and clinical practices. his work has not only contributed to theoretical Immuno - gene therapy advancements but has also informed practical applications that benefit patients facing challenging diagnoses.

Legacy and future contributions 🔮

With an enduring commitment to advancing cancer research, jerzy trojan continues to influence the field through his current role as a visiting professor and research director. his legacy is evident in the ongoing projects aimed at improving cancer treatment outcomes, particularly through innovative therapeutic strategies. as he continues to publish and mentor the next generation of researchers, his contributions will undoubtedly have a lasting impact on the future of oncology and gene therapy.

Notable Publications 

  • Title: Precancerous Disease Systemic Lupus Erythematosus–The Role of BAFF in Corticosteroids Treatment
    Author: J. Trojan et al.
    Journal: Medical Research and Its Applications, Vol. 6, Pages 114-127
    DOI: 10.9734/bpi/mria/v6/7520C
    Publication Date: June 3, 2024
  • Title: Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma
    Author: J. Trojan
    Journal: Current Medicinal Chemistry, Vol. 31, Pages 1982-2002
    DOI: 10.2174/0109298673231106095141
    Publication Date: March 11, 2024
  • Title: Establishment of Cancer Gene Therapy
    Author: J. Trojan
    Journal: Cambridge Scholars Publishing
    Publication Date: March 2, 2023
  • Title: Neoplastic brain, glioblastoma and immunotherapy
    Author: J. Trojan et al.
    Journal: In: Brain and Spinal Tumors - Primary and Secondary, Ed. L.R. Morgan, F.B. Sarica, InTechOpen
    Publication Date: 2020
  • Title: In vitro technical aspects of Anti–Gene IGF-I vaccines against glioma
    Author: J. Trojan et al.
    Journal: IBR, Vol. 3(1), Pages 43-48
    Publication Date: 2019

Prof. Zhiguo Wang – Polypharmacology – Outstanding Scientist Award

Posted on by Innovator Awards

Prof. Zhiguo Wang - Polypharmacology - Outstanding Scientist Award

Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Bidirectional Complications among Chronic Conditions, Jinan University, China - China 

Author Profile

SCOPUS 

ORCID

GOOGLE SCHOLAR

Early academic pursuits 🎓

Zhiguo Wang embarked on his academic journey with a strong foundation in pharmacology, pursuing his studies at Harbin Medical University in Heilongjiang, China. His early work laid the groundwork for a distinguished career focused on understanding chronic diseases and their complex interrelations. His rigorous training and commitment to research established him as a formidable scholar in the field of cardiovascular and chronic disease research.

Professional endeavors 🏢

Throughout his career, Zhiguo has held numerous prestigious positions, demonstrating his leadership in the medical and research communities. He is currently the Director and Professor at the Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Chronic Disease Complex Complications at Jinan University in Guangzhou, China. His role as a chief scientist and professor across various departments at the First Affiliated Hospital of Jinan University reflects his multifaceted expertise. Additionally, he has contributed significantly as a Distinguished Professor at Harbin Medical University and held a visiting professorship at the Montreal Heart Institute in Canada.

Contributions and research focus 🔬

Zhiguo's research focuses on the mechanistic and translational aspects of chronic diseases, particularly the bidirectional complications arising from these conditions. He has pioneered studies that explore the pathophysiology of cardiovascular diseases and their links to metabolic disorders. His work employs innovative Polypharmacology methodologies to investigate the underlying mechanisms of disease progression and to develop effective therapeutic strategies, aiming to improve patient outcomes in chronic disease management.

Accolades and recognition 🏅

Zhiguo Wang has received numerous accolades for his contributions to medical research, including being a Fellow of the American Heart Association (FAHA) and a Polypharmacology Fellow of the European Society of Cardiology (FESC). His recognition as a Marion L. Munro Research Scholar by the Canadian Diabetes Association further underscores his impactful research in chronic disease mechanisms. His extensive publication record in high-impact journals reflects his influence and standing in the academic community.

Impact and influence 🌍

Zhiguo's research has made a significant impact on the understanding of chronic diseases and their complications, influencing both clinical practice and public health strategies. His work is instrumental in bridging the gap between basic science and clinical applications, ultimately contributing to improved therapeutic approaches Polypharmacology for patients suffering from chronic conditions. He is a sought-after speaker and mentor, inspiring the next generation of researchers in his field.

Legacy and future contributions 🔮

As a leader in chronic disease research, Zhiguo Wang’s legacy is built on his commitment to advancing scientific knowledge and improving patient care. His ongoing research aims to unravel the complexities of chronic disease interactions and to foster innovative therapeutic strategies. With a focus on translational research, Zhiguo's future contributions are poised to drive significant advancements in understanding and treating chronic conditions, leaving a lasting impact on the field and enhancing healthcare outcomes globally.

Notable Publications 

Topical GDF11 accelerates skin wound healing in both type 1 and 2 diabetic mouse models  2020(9)

Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current 2020(8)

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis 2020(38)

Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice 2019(22)

Systematic analysis of intestinal microRNAs expression in HCC: Identification of suitable reference genes in fecal samples 2019(4)